Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Daxor Corp DXR

Healthcare Medical Devices

Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific... see more

Add To Watchlist

Recent & Breaking News (NDAQ:DXR)

Newly Published Study Demonstrates Clinical Utility of Daxor's Blood Volume (BVA-100®) Diagnostic in the Assessment of Postural Tachycardia Syndrome (POTS)

GlobeNewswire April 29, 2021

DAXOR CORPORATION TO PARTICIPATE IN BENZINGA BIOTECH SMALL CAP CONFERENCE

GlobeNewswire March 18, 2021

Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference

GlobeNewswire March 16, 2021

DAXOR CORPORATION ANNOUNCES NOVEL FLUORESCENT TRACER AND PHASE-TWO US AIR FORCE CONTRACT AWARD OF $750,000 FOR POINT-OF-CARE OPTICAL BLOOD VOLUME ANALYZER

GlobeNewswire March 15, 2021

Daxor to Present at the H.C. Wainwright Global Life Sciences Conference

GlobeNewswire March 4, 2021

Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020

GlobeNewswire February 26, 2021

DAXOR CORPORATION RECEIVES ISO 13485 QUALITY MANAGEMENT SYSTEM CERTIFICATION FOR THE BLOOD VOLUME ANALYZER (BVA-100®)

GlobeNewswire February 19, 2021

DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-OF-CARE BLOOD VOLUME ANALYZER

GlobeNewswire February 5, 2021

New Research Demonstrates the Clinical Utility with Daxor's Blood Volume Analyzer (BVA-100®) in Critical Care

GlobeNewswire February 4, 2021

DAXOR CORPORATION TO EXHIBIT AT THE SOCIETY FOR CRITICAL CARE MEDICINE 50TH CONGRESS VIRTUAL EVENT

GlobeNewswire January 26, 2021

DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH L1 ENTERPRISES GOVERNMENT DISTRIBUTOR

GlobeNewswire January 13, 2021

Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference

GlobeNewswire January 8, 2021

Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.

GlobeNewswire December 10, 2020

Daxor Corporation to Present at the 13th Annual LD Micro Main Event 2020

GlobeNewswire December 9, 2020

THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY

GlobeNewswire November 19, 2020

OREGON HEALTH & SCIENCE UNIVERSITY JOINS MULTICENTER COVID-19 BVA-100® STUDY

GlobeNewswire October 29, 2020

Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl

GlobeNewswire October 12, 2020

The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020

Accesswire October 8, 2020

New Research Shows Daxor's BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Presented at the Heart Failure Society of America Meeting 2020

GlobeNewswire October 6, 2020

New Research Demonstrates Daxor BVA-100® Blood Test Provides "Extremely Cost-Effective" Improvement in Patient Life Span at the Heart Failure Society of America Annual Scientific Meeting 2020

GlobeNewswire October 5, 2020